Anstella Dolores Robinson, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Robinson’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G62964 · Current
Licensed to practise in California · since 1988 · expires 2027-06-30 · Creighton University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$27,680
Medicare paid this office $27,680 for 245 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 76 | $10,221 | $134 |
| Return visit (30+ min) | 103 | $7,880 | $75 |
| Sleep study in sleep lab (6 years or older) | 40 | $4,122 | $101 |
| Long return visit (40+ min) | 29 | $3,399 | $117 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 19 | $1,938 | $102 |
Who their Medicare patients are
245 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 8% · Women 45% · Also on Medicaid 18% · Health risk score 1.28. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 73% · Coronary heart disease 33% · Diabetes 30% · Depression 25% · Chronic kidney disease 24% · Atrial fibrillation 24% · Heart failure 17% · Cancer 16% · COPD 9% · Dementia 7% · Stroke 7%.
The office billed $180,346, Medicare allowed $41,561 and paid $27,680; for 273 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 245 | 273 | 73 | 1.28 | $180,346 | $27,680 |
| 2023 | 493 | 657 | 72 | 1.16 | $385,667 | $67,178 |
| 2022 | 437 | 586 | 71 | 1.24 | $327,373 | $60,992 |
| 2021 | 472 | 608 | 71 | 1.25 | $392,944 | $69,183 |
| 2020 | 395 | 523 | 70 | 1.22 | $293,459 | $38,877 |
| 2019 | 528 | 685 | 71 | 1.32 | $244,981 | $61,670 |
| 2018 | 402 | 558 | 71 | 1.21 | $205,523 | $48,720 |
| 2017 | 421 | 565 | 70 | 1.31 | $222,052 | $46,646 |
| 2016 | 476 | 666 | 70 | 1.25 | $245,642 | $51,589 |
| 2015 | 440 | 639 | 70 | 1.31 | $218,920 | $47,933 |
| 2014 | 514 | 703 | 69 | 1.09 | $234,549 | $55,938 |
| 2013 | 383 | 496 | 68 | 1.13 | $113,885 | $26,214 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 296 | $26,181 | $82 |
| New patient visit (60+ min) | 157 | $22,705 | $145 |
| Sleep study in sleep lab (6 years or older) | 119 | $12,392 | $104 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 42 | $4,614 | $110 |
2022: 4 services
| Return visit (30+ min) | 249 | $22,848 | $81 |
| New patient visit (60+ min) | 139 | $21,006 | $151 |
| Sleep study in sleep lab (6 years or older) | 102 | $10,829 | $105 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 35 | $3,935 | $112 |
2021: 6 services
| New patient visit (60+ min) | 149 | $24,194 | $162 |
| Return visit (30+ min) | 210 | $18,696 | $82 |
| Long return visit (40+ min) | 94 | $12,453 | $131 |
| Sleep study in sleep lab (6 years or older) | 70 | $7,513 | $107 |
| New patient visit (45+ min) | 42 | $4,080 | $97 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 18 | $2,064 | $115 |
2020: 10 services
| Return visit (30+ min) | 218 | $15,091 | $66 |
| Sleep study in sleep lab (6 years or older) | 59 | $6,402 | $109 |
| Extended patient service without direct patient contact, first hour | 51 | $5,220 | $102 |
| New patient visit (30+ min) | 74 | $4,850 | $66 |
| New patient visit (60+ min) | 23 | $2,269 | $99 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,310 | $109 |
| New patient visit (45+ min) | 11 | $1,217 | $111 |
| Short return visit (20+ min) | 13 | $610 | $47 |
| Short return visit | 19 | $398 | $21 |
| Telehealth originating site facility fee | 12 | $256 | $21 |
2019: 6 services
| Return visit (30+ min) | 304 | $22,075 | $67 |
| New patient visit (60+ min) | 137 | $18,945 | $138 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 85 | $10,572 | $105 |
| Sleep study in sleep lab (6 years or older) | 60 | $6,395 | $107 |
| New patient visit (30+ min) | 12 | $814 | $68 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $504 | $46 |
2018: 6 services
| Return visit (30+ min) | 223 | $16,762 | $65 |
| New patient visit (60+ min) | 84 | $11,899 | $142 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 82 | $9,691 | $105 |
| Sleep study in sleep lab (6 years or older) | 54 | $5,637 | $101 |
| Long return visit (40+ min) | 35 | $2,826 | $81 |
| New patient visit (30+ min) | 17 | $1,077 | $63 |
2017: 7 services
| Return visit (30+ min) | 241 | $18,796 | $66 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 80 | $8,934 | $106 |
| New patient visit (60+ min) | 47 | $6,572 | $140 |
| Sleep study in sleep lab (6 years or older) | 51 | $5,227 | $99 |
| Long return visit (40+ min) | 48 | $4,446 | $93 |
| New patient visit (30+ min) | 26 | $1,513 | $58 |
| Sleep study including heart rate, breathing, airflow, and effort | 13 | $717 | $55 |
2016: 8 services
| Return visit (30+ min) | 269 | $21,790 | $65 |
| Sleep study in sleep lab (6 years or older) | 67 | $7,211 | $106 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 65 | $7,185 | $109 |
| New patient visit (60+ min) | 51 | $7,068 | $139 |
| Long return visit (40+ min) | 59 | $5,241 | $89 |
| Short return visit (20+ min) | 27 | $958 | $35 |
| Short return visit | 39 | $737 | $19 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $605 | $55 |
2015: 7 services
| Return visit (30+ min) | 241 | $19,579 | $62 |
| New patient visit (60+ min) | 50 | $6,658 | $133 |
| Sleep study in sleep lab (6 years or older) | 61 | $6,580 | $108 |
| Long return visit (40+ min) | 64 | $6,161 | $96 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 47 | $5,328 | $107 |
| Short return visit (20+ min) | 46 | $2,086 | $44 |
| Short return visit | 32 | $614 | $19 |
2014: 7 services
| Return visit (30+ min) | 327 | $27,013 | $65 |
| New patient visit (60+ min) | 72 | $10,430 | $145 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 58 | $6,591 | $114 |
| Sleep study in sleep lab (6 years or older) | 44 | $4,788 | $106 |
| Long return visit (40+ min) | 45 | $4,333 | $96 |
| New patient visit (45+ min) | 14 | $1,394 | $100 |
| Short return visit | 39 | $804 | $21 |
2013: 7 services
| Short return visit (20+ min) | 205 | $10,028 | $40 |
| Return visit (30+ min) | 87 | $5,860 | $66 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 30 | $3,403 | $110 |
| Sleep study in sleep lab (6 years or older) | 23 | $2,347 | $102 |
| New patient visit (15+ min) | 53 | $2,075 | $39 |
| New patient visit (30+ min) | 26 | $1,650 | $63 |
| Short return visit | 21 | $452 | $22 |
Medicaid work
$3,457 in 2024
Medicaid paid $3,457 for 25 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 12 | $2,202 |
| New patient visit (60+ min) | 13 | $1,256 |
| 2024 | 25 | 2 | 13 | $3,457 |
| 2023 | 95 | 2 | 15 | $5,372 |
| 2022 | 129 | 3 | 21 | $5,582 |
| 2021 | 25 | 2 | 13 | $1,422 |
| 2019 | 56 | 2 | 15 | $3,663 |
| 2018 | 25 | 1 | 13 | $1,142 |
See the largest Medicaid services in earlier years
2023
| New patient visit (60+ min) | 42 | $3,782 |
| Return visit (30+ min) | 53 | $1,590 |
2022
| New patient visit (60+ min) | 80 | $3,770 |
| Return visit (30+ min) | 36 | $1,083 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 13 | $730 |
2021
| New patient visit (45+ min) | 13 | $1,018 |
| Return visit (30+ min) | 12 | $404 |
2019
| New patient visit (60+ min) | 28 | $2,462 |
| Return visit (30+ min) | 28 | $1,201 |
2018
| Return visit (30+ min) | 25 | $1,142 |
Drugs they prescribed that Part D paid
$8,373
Pharmacies billed $8,373 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
43 generic and 17 brand-name prescriptions · $8,373 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belsomra | 14 | $6,072 | $434 |
| Zaleplon | 15 | $235 | $16 |
Year by year
| 2024 | 60 | 15 | None | 28% | $8,373 |
| 2023 | 72 | 14 | None | 36% | $9,247 |
| 2022 | 92 | 15 | None | 18% | $26,240 |
| 2021 | 63 | 15 | None | 37% | $12,734 |
| 2020 | 66 | None | 0% (0) | None | $23,143 |
| 2019 | 80 | 20 | None | 14% | $20,954 |
| 2018 | 81 | 25 | None | None | $21,628 |
| 2017 | 139 | 25 | 0% (0) | None | $23,063 |
| 2016 | 93 | 22 | None | None | $25,094 |
| 2015 | 115 | 34 | None | 10% | $13,956 |
| 2014 | 125 | 40 | 0% (0) | 12% | $12,950 |
| 2013 | 115 | 31 | None | 10% | $4,859 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Belsomra | 12 | $5,455 | $455 |
| Zaleplon | 15 | $166 | $11 |
2022: 3 drugs
| Gabapentin | 11 | $146 | $13 |
| Zolpidem | 15 | $136 | $9 |
| Zaleplon | 17 | $102 | $6 |
2021: 2 drugs
| Belsomra | 13 | $5,260 | $405 |
| Zaleplon | 13 | $198 | $15 |
2020: 2 drugs
| Methamphetamine | 12 | $16,617 | $1,385 |
| Zolpidem | 15 | $63 | $4 |
2019: 3 drugs
| Methamphetamine | 11 | $15,232 | $1,385 |
| Belsomra | 11 | $3,956 | $360 |
| Gabapentin | 12 | $133 | $11 |
2018: 1 drug
| Zaleplon | 12 | $411 | $34 |
2017: 7 drugs
| Methamphetamine | 12 | $19,200 | $1,600 |
| Modafinil | 13 | $624 | $48 |
| Eszopiclone | 14 | $461 | $33 |
| Zaleplon | 17 | $376 | $22 |
| Zolpidem | 19 | $237 | $12 |
| Fluticasone Propionate | 12 | $187 | $16 |
| Gabapentin | 19 | $145 | $8 |
2016: 1 drug
| Fluticasone Propionate | 16 | $212 | $13 |
2015: 3 drugs
| Fluticasone Propionate | 39 | $459 | $12 |
| Amitriptyline | 12 | $450 | $37 |
| Zolpidem | 11 | $272 | $25 |
2014: 4 drugs
| Fluticasone Propionate | 40 | $657 | $16 |
| Pramipexole Dihydrochloride | 12 | $247 | $21 |
| Clonazepam | 15 | $242 | $16 |
| Zolpidem | 21 | $143 | $7 |
2013: 5 drugs
| Fluticasone Propionate | 27 | $674 | $25 |
| Gabapentin | 13 | $293 | $23 |
| Pramipexole Dihydrochloride | 13 | $173 | $13 |
| Clonazepam | 21 | $89 | $4 |
| Zolpidem | 12 | $72 | $6 |
Money from drug and device companies
$104 in 2025
| 2025 | 1 | 1 | None | $104 |
| 2023 | 1 | 2 | None | $102 |
| 2022 | 1 | 1 | None | $75 |
| 2019 | 1 | 1 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Jazz Pharmaceuticals | None | $104 | 1 payment
|
See the published payment
| Jazz Pharmaceuticals | Meals · 2025-06-09 | None | $104 |
See earlier years (2023, 2022, 2019)
2023: $102
| Jazz Pharmaceuticals | Xywav | $102 | 2 payments
|
2022: $75
| Jazz Pharmaceuticals | Xywav | $75 | 1 payment
|
2019: $41
| Jazz Pharmaceuticals | Xyrem | $41 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1023158730
- Licence
- CA G062964California G62964: Current · expires 2027-06-30
- Trained
- Creighton University School of Medicine, 1984
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RS0012X (207RS0012X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-02-08
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 401 Quarry Rd, Palo Alto, CA, 94304